Professor Mike Clarke
Contact information
Mike Clarke
BA, DPhil
- Director of the Northern Ireland Clinical Trials Unit
- Northern Ireland Methodology Hub Lead, Queen’s University, Belfast
Professor Mike Clarke joined the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) in 1989 following a BA in chemistry and while finishing his DPhil on the history and epidemiology of suicide at the University of Oxford. Since then, he has been part of the Secretariat for the breast cancer overview, with a particular focus on the effects of ovarian ablation or suppression for women with early breast cancer.
He has nearly 30 years’ experience in the design and conduct of rigorous assessments of the effects of interventions through the use of randomised trials and systematic reviews.
Mike was Director of the UK Cochrane Centre from 2002 to 2011 and now leads the Northern Ireland Methodology Hub at Queen’s University, Belfast and is Director of the Northern Ireland Clinical Trials Unit.
Recent publications
-
Inclusion of under-served groups in trials: an audit at a UK primary care clinical trials unit.
Journal article
Burrow R. et al, (2025), Trials, 26
-
Inclusion of under-served groups in trials: an audit at a UK primary care clinical trials unit
Poster
BURROW R. et al, (2024)
-
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.
Journal article
Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150
-
Primary cam morphology; bump, burden or bog-standard? A concept analysis.
Journal article
Dijkstra HP. et al, (2021), Br J Sports Med
-
Patient and Public Involvement in Research: A Journey to Co-Production
Journal article
Price A. et al, (2021), Patient Education and Counseling